- Home
- CSTL vs BTO Comparison
CSTL vs BTO Comparison
Compare CSTL & BTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- BTO
- Stock Information
- Founded
- CSTL 2007
- BTO 1994
- Country
- CSTL United States
- BTO United States
- Employees
- CSTL N/A
- BTO N/A
- Industry
- CSTL Medical Specialities
- BTO Investment Managers
- Sector
- CSTL Health Care
- BTO Finance
- Exchange
- CSTL Nasdaq
- BTO Nasdaq
- Market Cap
- CSTL 576.3M
- BTO 670.7M
- IPO Year
- CSTL 2019
- BTO N/A
- Fundamental
- Price
- CSTL $19.78
- BTO $33.93
- Analyst Decision
- CSTL Strong Buy
- BTO
- Analyst Count
- CSTL 6
- BTO 0
- Target Price
- CSTL $40.00
- BTO N/A
- AVG Volume (30 Days)
- CSTL 403.1K
- BTO 54.2K
- Earning Date
- CSTL 05-01-2025
- BTO 01-01-0001
- Dividend Yield
- CSTL N/A
- BTO 9.13%
- EPS Growth
- CSTL N/A
- BTO N/A
- EPS
- CSTL 0.62
- BTO N/A
- Revenue
- CSTL $332,069,000.00
- BTO N/A
- Revenue This Year
- CSTL N/A
- BTO N/A
- Revenue Next Year
- CSTL $6.01
- BTO N/A
- P/E Ratio
- CSTL $32.29
- BTO N/A
- Revenue Growth
- CSTL 51.09
- BTO N/A
- 52 Week Low
- CSTL $16.97
- BTO $22.95
- 52 Week High
- CSTL $35.84
- BTO $32.81
- Technical
- Relative Strength Index (RSI)
- CSTL 36.62
- BTO 46.87
- Support Level
- CSTL $19.22
- BTO $33.25
- Resistance Level
- CSTL $20.30
- BTO $34.62
- Average True Range (ATR)
- CSTL 0.81
- BTO 0.82
- MACD
- CSTL 0.23
- BTO 0.22
- Stochastic Oscillator
- CSTL 43.33
- BTO 69.11
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.
About BTO John Hancock Financial Opportunities Fund
John Hancock Financial Opportunities Fund is the United States based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. The company invests in banks, capital markets, Insurance, Mortage Real Estate Investment trust, Health Care REITs, Diversified REITs, Office REITs.